The current pandemic caused by COVID-2019 is continuing to slow the world down with more & more cases everyday. The total confirmed cases has reached seven hundred thousand people world wide. Surgeon General of the United States, Jerome Adams, warns the public not to travel other than get to essential items. COVID-2019 is potentially up to 25 times more aggressive in spreading compared to the seasonal flu. So what can we do? I believe there is success in research currently being conducted on patients in France and South Korea recently that are proving to be helpful. Hydroxychloroquine and Azithromycin are current drugs that are being tested, that can potentially be a vaccine COVID-2019. Hydroxychloroquine is typically a drug that treats malaria patients, which is able to open more zinc ion protein channels of human cells and allow for more zinc to flow in, in order for the zinc to hinder the viruses +ssRNA replication. Given along with Azithromycin, which is used to treat many different types of infections caused by bacteria, such as respiratory infections, skin infections, ear infections, eye infections, and sexually transmitted diseases. These drugs are under screening currently and the FDA is expediting the processes in order for them to be available and labeled as a treatment for COVID-2019. The drugs ore in phase II of the screening process and we are excited to get this virus under control.
AGSC 5110 Research Methods 